Used primarily as an antiplatelet agent to prevent blood clots. It is effective in treating ischemic cerebrovascular diseases by inhibiting thromboxane synthase, which reduces the formation of thromboxane A2, a substance that promotes platelet aggregation and vasoconstriction. This makes it valuable in managing conditions like cerebral infarction and transient ischemic attacks. Additionally, it may be used in research settings to study platelet function and related cardiovascular disorders. Always administered under medical supervision to ensure proper dosage and minimize potential side effects.